RU2010152024A - DALARGIN-CONTAINING INTRANASAL COMPOSITION AS A SPRAY, METHOD FOR ITS MANUFACTURE AND APPLICATION FOR TREATMENT OF GASTROENTEROLOGICAL DISEASES - Google Patents
DALARGIN-CONTAINING INTRANASAL COMPOSITION AS A SPRAY, METHOD FOR ITS MANUFACTURE AND APPLICATION FOR TREATMENT OF GASTROENTEROLOGICAL DISEASES Download PDFInfo
- Publication number
- RU2010152024A RU2010152024A RU2010152024/10A RU2010152024A RU2010152024A RU 2010152024 A RU2010152024 A RU 2010152024A RU 2010152024/10 A RU2010152024/10 A RU 2010152024/10A RU 2010152024 A RU2010152024 A RU 2010152024A RU 2010152024 A RU2010152024 A RU 2010152024A
- Authority
- RU
- Russia
- Prior art keywords
- dalargin
- water
- spray
- composition
- loading
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Даларгинсодержащая интраназальная композиция в виде спрея, содержащая в качестве активного вещества даларгин и вспомогательные вещества. ! 2. Композиция по п.1, характеризующаяся тем, что она содержит даларгин и вспомогательные вещества при следующем соотношении компонентов, мас.%: ! даларгин 26,12-33,11 вспомогательные вещества 66,89-73,88 ! 3. Композиция по п.2, характеризующаяся тем, что она содержит в качестве вспомогательных веществ натрия хлорид, бензалкония хлорид и воду при следующем соотношении компонентов, мас.%: ! даларгин 26,12-33,11 натрия хлорид 59,6-65,83бензалкония хлорид 0,66-0,73 вода остальное ! 4. Композиция по п.3, характеризующаяся тем, что она содержит в качестве воды воду для инъекций. ! 5. Композиция по п.3, характеризующаяся тем, что она содержит в качестве воды очищенную воду. ! 6. Способ изготовления даларгинсодержащей интраназальной композиции в виде спрея, включающий подачу в снабженную мешалкой емкость воды, загрузку в емкость при перемешивании натрия хлорида, последующую загрузку при перемешивании бензалкония хлорида, осуществление перемешивания до полного растворения компонентов, загрузку даларгина с перемешиванием до полного его растворения, осуществление стерилизующей фильтрации раствора и розлив с дозированием полученного раствора во флаконы и их герметизацию микроспреерами. ! 7. Способ по п.6, характеризующийся тем, что загружают натрия хлорид в емкость до получения 0,9%-го раствора. ! 8. Способ по п.6 или 7, характеризующийся тем, что после загрузки в емкость даларгина осуществляют перемешивание раствора в течение 20-25 мин. ! 9. Способ по п.8, характеризующийся тем, что осуществляют ст� 1. Dalargin-containing intranasal composition in the form of a spray containing dalargin and excipients as an active substance. ! 2. The composition according to claim 1, characterized in that it contains dalargin and excipients in the following ratio of components, wt.%:! dalargin 26.12-33.11 excipients 66.89-73.88! 3. The composition according to claim 2, characterized in that it contains sodium chloride, benzalkonium chloride and water as auxiliary substances in the following ratio, wt.%:! dalargin 26.12-33.11 sodium chloride 59.6-65.83 benzalkonium chloride 0.66-0.73 water the rest! 4. The composition according to claim 3, characterized in that it contains water for injection as water. ! 5. The composition according to claim 3, characterized in that it contains purified water as water. ! 6. A method of manufacturing a dalargin-containing intranasal composition in the form of a spray, comprising supplying water to a tank equipped with a stirrer, loading sodium chloride into a container with stirring, subsequent loading of benzalkonium chloride with stirring, mixing until the components are completely dissolved, loading of dalargin with stirring until it is completely dissolved, sterilizing solution filtration and dispensing with dosing of the resulting solution into vials and sealing them with microspreaders. ! 7. The method according to claim 6, characterized in that sodium chloride is loaded into a container until a 0.9% solution is obtained. ! 8. The method according to claim 6 or 7, characterized in that after loading into the container of dalargin, the solution is mixed for 20-25 minutes. ! 9. The method according to claim 8, characterized in that they carry out
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010152024/10A RU2010152024A (en) | 2010-12-20 | 2010-12-20 | DALARGIN-CONTAINING INTRANASAL COMPOSITION AS A SPRAY, METHOD FOR ITS MANUFACTURE AND APPLICATION FOR TREATMENT OF GASTROENTEROLOGICAL DISEASES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010152024/10A RU2010152024A (en) | 2010-12-20 | 2010-12-20 | DALARGIN-CONTAINING INTRANASAL COMPOSITION AS A SPRAY, METHOD FOR ITS MANUFACTURE AND APPLICATION FOR TREATMENT OF GASTROENTEROLOGICAL DISEASES |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2010152024A true RU2010152024A (en) | 2012-06-27 |
Family
ID=46681519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010152024/10A RU2010152024A (en) | 2010-12-20 | 2010-12-20 | DALARGIN-CONTAINING INTRANASAL COMPOSITION AS A SPRAY, METHOD FOR ITS MANUFACTURE AND APPLICATION FOR TREATMENT OF GASTROENTEROLOGICAL DISEASES |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2010152024A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
-
2010
- 2010-12-20 RU RU2010152024/10A patent/RU2010152024A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2600440C3 (en) | SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND N- (8- (2-HYDROXYBENZOYL) AMINO) CAPRYLIC ACID SALT | |
ATE470443T1 (en) | INDOL-1-YL ACID DERIVATIVES | |
RU2016135039A (en) | COMPOSITION FOR TREATMENT OF SURFACE DEFECTS | |
TW200611694A (en) | Liquid composition for veterinary medicine, process for its preparation and use thereof | |
PE20130728A1 (en) | COMPLEX OBTAINED FROM MIXTURES OF HYALURONIC ACID OR A SALT OF THE SAME AND CHONDROITIN SULPHATE | |
RU2013107744A (en) | BIMATOPROST AND THYMOLOL SOLUTIONS NOT CONTAINING CONSERVANTS | |
RU2010152024A (en) | DALARGIN-CONTAINING INTRANASAL COMPOSITION AS A SPRAY, METHOD FOR ITS MANUFACTURE AND APPLICATION FOR TREATMENT OF GASTROENTEROLOGICAL DISEASES | |
RU2019119405A (en) | DALBAVANCIN LYOPHILIZED PHARMACEUTICAL COMPOSITIONS | |
JP5368471B2 (en) | Sustained release bactericidal and antibacterial agent for cationic electrodeposition coating system | |
ATE446763T1 (en) | PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OSTEOARTHRITIS WITH CLODRONIC ACID AND HYALURONIC ACID | |
RU2015114709A (en) | STABLE INJECTION COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE | |
GEP20125602B (en) | Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and usage thereof | |
CN102670496A (en) | Cimetidine injection and preparation process | |
RU2010148281A (en) | ROAD MIX | |
RU2011130246A (en) | PHYTOESTROGENIC COMPOSITIONS FOR PREVENTING OR TREATING SYMPTOMS CONNECTED WITH MENOPAUSE | |
RU2008137463A (en) | DRUG FOR TREATMENT AND PREVENTION OF DISORDERS OF SELENIUM EXCHANGE FOR AGRICULTURAL ANIMALS | |
RU2008132922A (en) | METHOD FOR TREATING DAMAGES OF ORGANISM SYSTEMS DUE TO ACTIVATION OF THE PEROXIDATION PROCESS PROCESS AND THE LIQUID PHARMACEUTICAL COMPOSITION FOR ITS IMPLEMENTATION | |
RU2011151678A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF INJECTION SOLUTION Possessing Nootropic, Neuroprotective and Anti-Alcoholic Activity and Method for its Preparation | |
RU2006118961A (en) | DRUG FOR TREATMENT OF PYROPLASMOSIS OF DOGS | |
RU2013146906A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF NASAL SPRAY BASED ON NALOXONE HYDROCHLORIDE AND METHOD FOR PRODUCING IT | |
RU2012105183A (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTION OF THE MITOMYCIN-O PROLIFERATIVE CELL REACTION | |
RU2014143264A (en) | MEDICINAL COMPOSITION AND SOFT MEDICINAL CAPSULE WITH A COMPLETED MEDICINAL COMPOSITION | |
RU2012152225A (en) | DENTAL PENCIL WITH CALCIUM NANOSUBSTANCE GLUCONATE FOR THE TREATMENT OF DISEASES CONNECTED WITH A DEFICIENCY OF CALCIUM | |
RU2008131510A (en) | PHARMACEUTICAL COMPOSITION AND KIT FOR TREATMENT OF TUMOR DISEASES | |
RU2021120897A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF EYE DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20121210 |